A comprehensive view of astrazeneca ab. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Australia: AstraZeneca Receives Patent for 'Methods of treating chronic kidney disease with dapagliflozin'
Published:
February 03, 2023
by Australian Government
|
Australia Patent: AstraZeneca Files Application for 'EGFR TKIs for use in the treatment of non-small cell lung cancer'
Published:
February 03, 2023
by Australian Government
|
Australia Patent: AstraZeneca UK, Daiichi Sankyo File Application for 'Combination of antibody-drug conjugate and ATR inhibitor'
Published:
February 03, 2023
by Australian Government
|
Australia Patent: AstraZeneca Files Application for 'Treatment of cardiometabolic disease with inhibitors of type I interferon signalling'
Published:
February 03, 2023
by Australian Government
|
Australia: AstraZeneca Receives Patent for 'PCSK9 inhibitors and methods of use thereof'
Published:
February 03, 2023
by Australian Government
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count